Both in Pharmaceuticals
Madrigal Pharmaceuticals vs BioMarin Pharmaceuticals
Over the past year MDGL returned +15.0% and BMRN returned +10.8%; their daily moves had a correlation of 0.26.
MDGL +15.0% BMRN +10.8%Growth of $1, one year, split-adjusted
| Metric | MDGL | BMRN |
|---|---|---|
| Price | $509.44 | $59.87 |
| Market cap | $11.77B | $11.59B |
| Today | −1.47% | +0.69% |
| 1 month | −4.6% | −7.4% |
| 6 months | +0.8% | +9.3% |
| Year to date | −12.5% | +0.7% |
| 1 year | +20.1% | +11.2% |
| Revenue growth (YoY) | +71.2% | +19.9% |
| Gross margin | 100.0% | 79.5% |
| Net margin | −15.9% | 4.5% |
| P/E (TTM) | — | 158.8× |
| Price / sales | 9.2× | 3.4× |
| Net cash | $498.0M | -$3.31B |
| Dividend yield | — | — |
| Volatility (60d) | 41.3% | 29.6% |
| Short % of float | 13.6% | 5.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).